M. Yalcin Et Al. , "Activation of the central cholinergic system mediates the reversal of hypotension by centrally administrated U-46619, a thromboxane A2 analog, in hemorrhaged rats," Brain Research , vol.1118, no.1, pp.43-51, 2006
Yalcin, M. Et Al. 2006. Activation of the central cholinergic system mediates the reversal of hypotension by centrally administrated U-46619, a thromboxane A2 analog, in hemorrhaged rats. Brain Research , vol.1118, no.1 , 43-51.
Yalcin, M., Cavun, S., Yilmaz, M. S., & Savci, V., (2006). Activation of the central cholinergic system mediates the reversal of hypotension by centrally administrated U-46619, a thromboxane A2 analog, in hemorrhaged rats. Brain Research , vol.1118, no.1, 43-51.
Yalcin, Murat Et Al. "Activation of the central cholinergic system mediates the reversal of hypotension by centrally administrated U-46619, a thromboxane A2 analog, in hemorrhaged rats," Brain Research , vol.1118, no.1, 43-51, 2006
Yalcin, Murat Et Al. "Activation of the central cholinergic system mediates the reversal of hypotension by centrally administrated U-46619, a thromboxane A2 analog, in hemorrhaged rats." Brain Research , vol.1118, no.1, pp.43-51, 2006
Yalcin, M. Et Al. (2006) . "Activation of the central cholinergic system mediates the reversal of hypotension by centrally administrated U-46619, a thromboxane A2 analog, in hemorrhaged rats." Brain Research , vol.1118, no.1, pp.43-51.
@article{article, author={Murat Yalcin Et Al. }, title={Activation of the central cholinergic system mediates the reversal of hypotension by centrally administrated U-46619, a thromboxane A2 analog, in hemorrhaged rats}, journal={Brain Research}, year=2006, pages={43-51} }